Pervasis Therapeutics since Nov 2005
Scientist III
Stryker Biotech Sep 2003 - Nov 2005
Lead Bioassay Analyst, Quality Control
Forticell Bioscience Inc. (formerly Ortec International Inc.) Oct 1998 - Aug 2003
Project Leader, R&D Cell Culture
Wyeth Pharmaceuticals Mar 1994 - Oct 1998
Senior Reseach Associate, Cellular and Viral Process Development
Education:
Cornell University 1989 - 1993
BS, Bioengineering
Us Patents
Methods And Devices For Minimally-Invasive Delivery Of Cell-Containing Flowable Compositions
Glenn Kanner - Plymouth MA, US Stephen August Bollinger - Mansfield MA, US Helen Marie Nugent - Needham MA, US Celina Choi - Brighton MA, US Desmond White - Oxford MA, US Yin Shan Ng - North Billerica MA, US
Assignee:
PERVASIS THERAPEUTICS, INC. - Cambridge MA
International Classification:
A61K 35/12 A61P 43/00 A61M 5/32 A61M 5/31
US Classification:
604190, 424 937, 604272
Abstract:
The present invention relates to a device for delivering a flowable composition comprising cells, wherein the flowable composition is in an amount effective to treat an injured or diseased site. The device comprises a delivery device adapted for minimally-invasive delivery of the flowable composition through which the flowable composition can be passed while maintaining the effectiveness and viability of the cells of the flowable composition. The present invention further relates to a method for delivering the flowable composition comprising cells. The method comprises the steps of percutaneously inserting a delivery device adapted for minimally-invasive delivery of the flowable composition through which the flowable composition can be passed while maintaining the effectiveness and viability of the cells of the flowable composition and administering the flowable composition at, adjacent to or in the vicinity of the injured or diseased site.
Celina Choi's Public Profile on Plaxo. Plaxo helps members like Celina Choi keep in touch with the people who really matter, helping them to connect, keep each